Skip to content

The clinical utility of next generation optical coherence tomography for accessory visual structurescoherence tomography

The clinical utility of next generation optical coherence tomography for accessory visual structurescoherence tomography - The clinical utility of OCT for accessory visual structures

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000019294
Enrollment
130
Registered
2015-12-01
Start date
2015-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

accessory visual structures

Interventions

Evaluating accessory visual structures in disease states using next generation optical coherence tomography Intervention frequency is 3 times
initial visit, postoperative monnths 2,6. Evaluating accessory visual structures in normal states using next generation optical coherence tomography Intervention frequency is one time.

Sponsors

Kyoto University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.patients who were diagnosed as lacrimal disease or eyelid tumor in Kyoto university 2.patients who are normal states in accessory visual structures

Exclusion criteria

Exclusion criteria: 1.patients who had allergy caused by rebamipido eye-drop 2.patients who didn't agree with this study 3.patients who were judged to be unsuitable to this study by us

Design outcomes

Primary

MeasureTime frame
Comparison between normal and disease states in lacrimal apparatus using OCT image

Secondary

MeasureTime frame
Comparison between benign and malignant eyelid tumor using OCT image

Countries

Japan

Contacts

Public ContactMasahiro Fujimoto

Kyoto University Graduate School of Medicine Department of Ophthalmology and Visual Sciences

m2fjmt@kuhp.kyoto-u.ac.jp075-751-3250

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026